Portland, OR — (SBWIRE) — 10/06/2017 — Pneumonia is indicated as a complex infection that affects the lower part of the respiratory tract along with deposition of a cough in the lungs. It may even occur as a consequence of an upper tract infection. Usually, it occurs in people with weakened immunity and generally occurs in older people and children. Biotechnological methods can be approached for testing of pneumonia such as enzyme-linked immunosorbent assay and polymerase chain reaction. The drivers that drive pneumonia testing market growth increase in the prevalence of pneumonia, the rise in awareness about early diagnosis and preventive measures of pneumonia, improvement in the healthcare sector. In addition, growing popularity of point of care (POC) testing has also fuelled the market growth. However, the high cost of the testing technology and limited detection capability as well as less accuracy of the test restraints the market growth. Moreover, technological advancements in the techniques of the testing will prove as an opportunity for the future growth of the market.
Get TOC and Sample Copy: https://www.alliedmarketresearch.com/request-toc-and-sample/3776
The report segments the market on the basis of the method, technology, end users, and region. Based on method, the market is segmented into immunodiagnostics, molecular diagnostics and point of care (POC) testing. Based on technology, the market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC) and others. Based on end users, the market is segmented into hospitals, diagnostic laboratories, homecare and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players in the market that are included are Abbott Laboratories, F-Hoffmann La Roche Ltd., Thermo Fischer Scientific Inc., Alere, Bio-Rad Laboratories Inc., Hologic Inc., DiaSorin S.p.A, Seracare, AdvanDx Inc., and Becton, Dickenson, and Company (BD).
Some key benefits:
-The study provides an in-depth analysis of the global pneumonia testing market along with the current trends and future estimations to elucidate the imminent investment pockets.
-Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
-Comprehensive quantitative analysis of the industry is provided for the period of 20162023 to assist stakeholders to capitalize on the prevailing market opportunities.
For more information on this press release visit: http://www.sbwire.com/press-releases/pneumonia-testing-market-by-method-technology-and-by-end-users-2023-874285.htm
Media Relations Contact